|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Luo G, Long J, Zhang B, et al: Stroma and
pancreatic ductal adenocarcinoma: An interaction loop. Biochim
Biophys Acta. 1826:170–178. 2012.PubMed/NCBI
|
|
3
|
Warshaw AL and Fernandez-del Castillo C:
Pancreatic carcinoma. N Engl J Med. 326:455–465. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Ma Q, Xu Q, et al: SDF-1/CXCR4
signaling induces pancreatic cancer cell invasion and
epithelial-mesenchymal transition in vitro through non-canonical
activation of Hedgehog pathway. Cancer Lett. 322:169–176. 2012.
View Article : Google Scholar
|
|
5
|
Pedrazzoli S, DiCarlo V, Dionigi R, et al:
Standard versus extended lymphadenectomy associated with
pancreatoduodenectomy in the surgical treatment of adenocarcinoma
of the head of the pancreas: a multicenter, prospective, randomized
study. Lymphadenectomy Study Group. Ann Surg. 228:508–517. 1998.
View Article : Google Scholar
|
|
6
|
Li Y, Kong D, Ahmad A, Bao B and Sarkar
FH: Pancreatic cancer stem cells: Emerging target for designing
novel therapy. Cancer Lett. May 20–2012.(Epub ahead of print).
|
|
7
|
Ni X, Yang J and Li M: Imaging-guided
curative surgical resection of pancreatic cancer in a xenograft
mouse model. Cancer Lett. 324:179–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Long J, Luo G, Liu C, et al: Development
of a unique mouse model for pancreatic cancer lymphatic metastasis.
Int J Oncol. 41:1662–1668. 2012.PubMed/NCBI
|
|
9
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
10
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo G, Yu X, Jin C, et al:
LyP-1-conjugated nanoparticles for targeting drug delivery to
lymphatic metastatic tumors. Int J Pharm. 385:150–156. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
15
|
Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH
and Liu LM: Identification of liver metastasis-related genes in a
novel human pancreatic carcinoma cell model by microarray analysis.
Cancer Lett. 283:84–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giodini A, Kallio MJ, Wall NR, et al:
Regulation of microtubule stability and mitotic progression by
survivin. Cancer Res. 62:2462–2467. 2002.PubMed/NCBI
|
|
17
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
19
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moriyama T, Ohuchida K, Mizumoto K, et al:
Enhanced cell migration and invasion of CD133+
pancreatic cancer cells cocultured with pancreatic stromal cells.
Cancer. 116:3357–3368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shah AN, Summy JM, Zhang J, Park SI,
Parikh NU and Gallick GE: Development and characterization of
gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol.
14:3629–3637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Li Y, Kong D, et al: Acquisition
of epithelialmesenchymal transition phenotype of
gemcitabine-resistant pancreatic cancer cells is linked with
activation of the notch signaling pathway. Cancer Res.
69:2400–2407. 2009. View Article : Google Scholar
|
|
23
|
Hong SP, Wen J, Bang S, Park S and Song
SY: CD44-positive cells are responsible for gemcitabine resistance
in pancreatic cancer cells. Int J Cancer. 125:2323–2331. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu F, Yao H, Zhu P, et al: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hatfield SD, Shcherbata HR, Fischer KA,
Nakahara K, Carthew RW and Ruohola-Baker H: Stem cell division is
regulated by the microRNA pathway. Nature. 435:974–978. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wellner U, Schubert J, Burk UC, et al: The
EMT-activator ZEB1 promotes tumorigenicity by repressing
stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495. 2009.
View Article : Google Scholar
|
|
27
|
Liu C, Kelnar K, Liu B, et al: The
microRNA miR-34a inhibits prostate cancer stem cells and metastasis
by directly repressing CD44. Nat Med. 17:211–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng H, Shi S, Cai X, et al: microRNA
signature for human pancreatic cancer invasion and metastasis. Exp
Ther Med. 4:181–187. 2012.PubMed/NCBI
|
|
29
|
Ji Q, Hao X, Zhang M, et al: MicroRNA
miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PLoS One. 4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leal JA and Lleonart ME: MicroRNAs and
cancer stem cells: Therapeutic approaches and future perspectives.
Cancer Lett. Apr 30–2012.(Epub ahead of print).
|
|
31
|
Ni X, Long J, Cen P, Chen L, Yang J and Li
M: Pancreatic cancer tumour initiating cells: the molecular
regulation and therapeutic values. J Cell Mol Med. 16:988–994.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu C, Teng ZQ, Santistevan NJ, et al:
Epigenetic regulation of miR-184 by MBD1 governs neural stem cell
proliferation and differentiation. Cell Stem Cell. 6:433–444. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo G, Jin C, Long J, et al: RNA
interference of MBD1 in BxPC-3 human pancreatic cancer cells
delivered by PLGA-poloxamer nanoparticles. Cancer Biol Ther.
8:594–598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Chen Y, Yu X, et al: Proteomic
analysis of differential proteins in pancreatic carcinomas: Effects
of MBD1 knock-down by stable RNA interference. BMC Cancer.
8:1212008. View Article : Google Scholar : PubMed/NCBI
|
